IPOs to Watch in 2026: Top Names and How to Analyze Them

The highest-priority IPOs to watch right now are Databricks, Stripe, Anthropic, OpenAI,, Shein, and Intel’s planned spinoff or restructuring vehicle. Your single next action: pull each company’s S-1 on SEC EDGAR or set a FilingsIQ filing-change alert so you catch every amendment the moment it posts.

Here is a quick-status snapshot before the full profiles below:

• Databricks — confidential S-1 filed; 2026 IPO widely anticipated; estimated valuation above $60 billion

• Stripe — no public S-1 filed as of mid-2026; direct listing or traditional IPO remains possible; valuation estimates range widely in press coverage

• Anthropic — pre-IPO; no S-1 filed; AI sector growth driver; backed by major strategic investors

• OpenAI — pre-IPO; no S-1 filed; restructuring to for-profit entity ongoing; timeline uncertain

• Shein — S-1 filed in the U.S. previously; regulatory and geopolitical hurdles remain; timing unclear

• Intel — restructuring underway; potential spinoff vehicles being evaluated; no S-1 filed for a standalone entity

Table of Contents

• The top IPOs to watch: mini-profiles and side-by-side comparison

• How the IPO process and S-1 timeline actually work

• What to look for in an S-1: an investor checklist

• Where and how to track IPOs and filing updates in real time

• Recent notable IPOs and quick lessons for investors

• Major risks and filing red flags investors should not ignore

• How professional analysts speed S-1 research with Filingsiq

• Key Takeaways

• The part of IPO research most analysts skip

• Filingsiq cuts S-1 research time for IPO analysts

• Authority sources and where to read the filings

• FAQ

The top IPOs to watch: mini-profiles and side-by-side comparison

Databricks

Databricks is the leading data and AI platform for enterprise analytics, competing directly with Snowflake in the cloud data warehouse and lakehouse space. The company filed a confidential S-1 with the SEC, a standard step that precedes a public filing by at least 15 days. Press coverage from U.S. News and Kiplinger place its anticipated valuation above $60 billion, driven by rapid revenue growth and deep enterprise penetration. Key risks include intense competition from cloud hyperscalers and customer concentration among large enterprises.

Quick take: Watch for the public S-1 to confirm revenue growth trajectory and gross margin. The confidential filing stage means material details are not yet public.

Stripe

Stripe processes payments for millions of businesses globally and has been one of the most-anticipated upcoming IPOs for several years. No public S-1 has been filed as of mid-2026. The company has explored both a direct listing and a traditional IPO. Valuation estimates in the press have ranged widely, reflecting uncertainty about timing and market conditions. Revenue quality and take-rate trends will be the first metrics to examine once a prospectus appears.

Quick take: Stripe’s delay is itself a signal. Track SEC EDGAR for any confidential submission activity before committing to a thesis.

Anthropic

Anthropic is an AI safety company building large language models, most notably the Claude series. It has attracted significant strategic investment but has not filed an S-1. The AI sector’s growth narrative is strong, but pre-revenue or early-revenue AI companies carry high valuation risk when public markets apply earnings multiples. Kiplinger includes Anthropic among the most-watched names for 2026.

Quick take: No filing means no verified financials. Monitor for a confidential S-1 submission as the first concrete timing signal.

OpenAI

OpenAI is restructuring from a capped-profit entity to a for-profit corporation, a prerequisite for a conventional IPO. No S-1 has been filed. The restructuring timeline and regulatory approvals will govern when a public offering becomes feasible. Revenue from ChatGPT and API licensing is substantial, but governance complexity and the nonprofit board’s retained interests add unusual risk-factor language to any future prospectus.

Quick take: The for-profit conversion is the gating event. Watch for SEC registration filings tied to the restructuring, not just an S-1.

Shein

Shein, the fast-fashion e-commerce platform, previously filed an S-1 in the U.S. Regulatory scrutiny over supply-chain practices, data privacy, and geopolitical considerations have complicated the timeline. IG International tracks Shein among major upcoming listings with a large estimated market cap. Retail investors should note that regulatory risk here is unusually high relative to most tech IPOs.

Quick take: Read the risk factors section of any updated S-1 filing with particular attention to regulatory and geopolitical disclosures before forming a position.

How the IPO process and S-1 timeline actually work

The S-1 prospectus is the foundational document for every traditional IPO. A company submits it to the SEC, which reviews and comments, and the company amends until the SEC declares the filing effective. That sequence typically takes 3–6 months from initial confidential submission to listing day, though market conditions, SEC comment volume, and business events can compress or extend it significantly.

Key milestones in order:

5. Listing day — Shares begin trading on Nasdaq or NYSE.

S-1 sections to read immediately upon filing:

• Use of proceeds — Where the IPO money goes; debt repayment is a yellow flag

Dates move for three primary reasons: adverse market conditions (a sharp equity selloff can pause a roadshow overnight), unresolved SEC comments that require material disclosure changes, and company-specific events such as a revenue miss or a regulatory action. When a company pulls or delays an IPO, the SEC filing record will show the withdrawal or a gap in amendments.

What to look for in an S-1: an investor checklist

Revenue quality is the single most important evaluator metric in an S-1. Specifically, you want to understand how revenue is recognized, not just how much there is. A company that front-loads contract revenue or uses aggressive percentage-of-completion accounting can show strong top-line growth while cash flow tells a different story.

Core checklist for S-1 evaluation:

• Revenue and revenue recognition — Read the accounting policy note. Watch for changes from prior periods or language like “we recognize revenue upon delivery of the performance obligation” without clear definition of what that obligation is.

• Gross margin and unit economics — Gross margin below 40% in a SaaS company or below 20% in a marketplace warrants explanation. Declining gross margin at scale is a structural concern.

• Cash burn and runway — Divide cash on hand by quarterly net cash used in operations. Less than 12 months of runway without the IPO proceeds is a material risk.

• Governance and management background — Check for prior SEC enforcement actions, restatements at previous companies, or board composition dominated by insiders.

• Related-party transactions — Disclosed in a dedicated section. Loans to executives, leases from founder-owned entities, or revenue from affiliated companies all warrant scrutiny.

• Legal contingencies — Quantified contingencies in the notes to financial statements can represent undisclosed liability. Unquantified ones are often more concerning.

• Customer concentration — If one customer represents more than 10% of revenue, that customer’s renewal risk is your risk.

• Accounting policy changes — A change in revenue recognition or capitalization policy between periods can artificially inflate growth metrics.

• Pro forma and non-GAAP adjustments — Stock-based compensation is the most commonly excluded item. Understand what GAAP earnings look like before accepting adjusted figures.

Pro Tip: Compare the risk factors section across S-1 amendment drafts. When a company quietly adds a new risk or expands an existing one between the initial filing and the S-1/A, that change often reflects a material development the company is required to disclose. FilingsIQ’s automated filing-diff feature surfaces these changes instantly.

Red-flag language to watch for: Risk factor language that reads “we have a history of net losses and may not achieve profitability” combined with a use-of-proceeds section showing the majority of funds going to debt repayment rather than growth investment is a pattern that has preceded significant post-IPO underperformance in multiple prior offerings. Read both sections together, not in isolation.

For a deeper framework on analyzing S-1 filings, FilingsIQ’s S-1 analysis guide walks through each section with annotated examples.

Kiplinger advises reading the founders’ letter and prospectus summary together, noting that the gap between management’s narrative and the actual risk disclosures is often where the real story lives.

Where and how to track IPOs and filing updates in real time

Primary tracking sources:

• SEC EDGAR — The authoritative source for all S-1 filings, amendments (S-1/A), and withdrawal notices. Free and updated in real time.

• Nasdaq IPO Calendar — Lists upcoming, priced, filed, and withdrawn IPOs with expected dates and price ranges. Note that expected dates are EDGAR-estimated, not official Nasdaq endorsements.

• Renaissance Capital IPO Calendar — Deal-level data including offer date, deal size, bookrunners, and post-IPO return benchmarks. Professionals use this to contextualize new issues against recent performance.

• Yahoo Finance IPO Calendar — Live calendar with symbol, exchange, date, and price range columns; useful for quick daily checks.

• FilingsIQ IPO Calendar — A curated calendar integrated with automated S-1 diff alerts and workspace tracking for subscribers.

How to set alerts:

1. Go to EDGAR’s full-text search and set an RSS feed or email alert for a specific company name combined with form type “S-1” or “S-1/A.”

2. On the Nasdaq IPO calendar, bookmark the filing and priced tabs and check them at market open.

3. Create a Google Alert for [Company name] + "S-1" + "confidential filing" to catch press coverage of pre-public submissions.

4. In FilingsIQ, create a workspace for each ticker you are monitoring. Enable filing-draft diff alerts so any amendment triggers an immediate notification with the changed text highlighted.

What to monitor daily once a company is on your watchlist:

• SEC amendments (S-1/A filings) that change the price range, share count, or risk disclosures

• Underwriter upsizes or downsizes, which signal institutional demand strength or weakness

• Lock-up schedule changes disclosed in amendments

• SEC comment letters and company responses (available on EDGAR under “correspondence”)

Real-time data feeds matter here. As IG International notes, companies frequently delay IPOs, and tracking SEC filing changes and comment-letter activity is often a better timing signal than press rumors. The same principle applies to real-time financial analytics more broadly: the edge comes from seeing changes as they happen, not after the fact.

Recent notable IPOs and quick lessons for investors

The August 2026 IPO calendar opened with a mix of biotechs and a regional bank, per Renaissance Capital’s week-ahead report:

• Braveheart Bio — $300 million deal at approximately $1.385 billion market cap. Lesson: Biotech IPOs at this size carry binary clinical-data risk. First-day pricing reflects institutional allocation, not retail consensus.

• Attovia Therapeutics — $200 million deal at approximately $649 million market cap. Lesson: Smaller biotech offerings with a single lead asset concentrate all risk in one pipeline event.

• River City Bank — Regional bank offering in the same week. Lesson: Bank IPOs trade on net interest margin and loan-book quality; read the financial statements before the prospectus summary.

• Vogenx — Listed in the same week’s calendar. Lesson: Lesser-known underwriters on a small deal require extra due diligence on the bookrunner’s track record.

Three behavioral patterns repeat across recent IPO cohorts. First-day pops driven by institutional allocation often give way to volatility in weeks two through six as retail buyers enter and early investors assess lock-up timelines. Mega-issuer lock-up expirations can materially increase float, as Renaissance Capital specifically flagged for SpaceX’s partial lock-up release. Biotech names with early clinical data pending at IPO carry event risk that can move the stock 30%–50% in either direction on a single readout.

Major risks and filing red flags investors should not ignore

Most post-IPO disappointments trace back to disclosures that were present in the S-1 but not read carefully. The following red flags should shift your posture from bullish to cautious:

Red-flag checklist:

• Revenue recognition caveats — Aggressive or ambiguous recognition policies inflate reported growth and can reverse when auditors or the SEC push back.

• Repeated accounting restatements — A history of restatements at the IPO company or at companies where the CFO previously worked is a governance signal.

• Heavy related-party transactions — Undisclosed or inadequately disclosed transactions between the company and insiders suggest weak board oversight.

• Weak auditor language — A going-concern qualification or an emphasis-of-matter paragraph in the audit opinion is a serious warning. A first-time audit from a non-Big Four firm on a large offering warrants scrutiny.

• Legal contingencies — Unquantified litigation exposure in the notes can represent material undisclosed liability.

• Extreme customer concentration — A single customer above 20% of revenue makes the company’s financial health dependent on one renewal decision.

• Inconsistent management disclosures across drafts — When the MD&A narrative changes materially between S-1 versions without a corresponding change in the financials, something has been reframed.

Defensive actions when you find a red flag:

1. Delay allocation until the post-IPO trading period provides price discovery independent of the roadshow.

2. Limit position size. Kiplinger recommends keeping total IPO exposure to 5%–10% of a portfolio at most.

3. Require post-IPO proof of execution: one full quarter of public financials before adding to a position.

4. Wait until lock-up expiry. If insiders sell aggressively at the first opportunity, that behavior is itself a data point.

Portfolio sizing for IPO exposure follows a consistent professional practice: treat the full position as speculative until the company has demonstrated it can meet public-company disclosure standards across at least two quarterly filings.

How professional analysts speed S-1 research with FilingsIQ

Analysts who cover IPOs systematically prioritize three things: detecting material changes between filing drafts, reviewing SEC comment letters for issues the company was forced to address, and assessing underwriter quality as a proxy for institutional demand. The workflow below reflects that priority order.

Step-by-step workflow:

• Create a workspace for the ticker in FilingsIQ. This centralizes all filings, amendments, and alerts in one place per company.

• Enable filing-draft diff alerts so that every S-1/A amendment triggers a notification with the changed text highlighted. Material changes to risk factors, financial statements, or use-of-proceeds language surface immediately.

• Extract key financial ratios from the financial statements: revenue growth rate, gross margin, operating cash flow margin, and cash runway. FilingsIQ’s AI summary pulls these from the filing automatically.

• Monitor insider and congressional trades using FilingsIQ’s congress trades tracker. Pre-IPO insider activity and post-IPO congressional disclosures can indicate conviction or concern from informed parties.

• Generate a research memo with one click. The memo captures the filing summary, key ratio changes, red-flag highlights, and a one-page investment-thesis snapshot exportable to your team workspace.

Pro Tip: The SEC comment letter exchange is public on EDGAR under “correspondence” for each filing. When the SEC asks a company to revise its revenue recognition disclosure or to quantify a previously unquantified contingency, that exchange tells you exactly what the regulator found unclear or aggressive. Reading it takes ten minutes and often reveals more than the S-1 itself.

The capabilities that matter most for IPO-focused research: automated S-1 diffs between amendment versions, red-flag highlighting tied to specific accounting and governance criteria, team workspace for collaborative annotation, and exportable research memos. FilingsIQ’s IPO analysis tool covers all four. For analysts building a structured research database around filings, the SEC filing analysis best practices guide covers workflow design in detail.

Professional investors use real-time data and insider trade monitoring to separate speculative IPOs from more defensible offerings. Automating the detection layer is what makes that separation practical at scale.

Key Takeaways

The most effective approach to IPO research is to read the S-1 before the roadshow, monitor every amendment for material changes, and size positions conservatively until post-IPO financials confirm the prospectus narrative.

Point	Details
Set EDGAR and FilingsiQ alerts	Enable S-1 and S-1/A alerts on EDGAR and FilingsIQ workspaces before any roadshow begins.
Run the S-1 checklist	Apply the revenue recognition, cash runway, and red-flag checklist to the top one or two names on your watchlist.
Size IPO exposure conservatively	Kiplinger advises limiting total IPO allocation to 5%–10% of a portfolio; treat each position as speculative until two public quarters are reported.
Monitor lock-up expirations	Lock-up releases can more than double tradable float, as Renaissance Capital flagged for SpaceX, creating post-IPO price pressure.
Use FilingsIQ for filing diffs	FilingsIQ’s automated S-1 diff alerts surface material changes between amendment drafts faster than manual EDGAR review.

The part of IPO research most analysts skip

Most watchlists focus on the names and the valuations. The more productive focus is the gap between what management says in the prospectus summary and what the risk factors actually disclose. Those two sections are written by different teams under different legal incentives, and the distance between them is often where the investment thesis either holds or breaks.

The companies on this list — Databricks, Stripe, Anthropic, OpenAI, Shein, and Intel’s potential spinoff vehicles — are all genuinely worth monitoring. But “worth monitoring” and “worth buying at IPO” are different conclusions. The S-1 is the only document that lets you make that distinction with evidence rather than narrative.

Waiting for post-IPO price discovery is not a passive strategy. It is a disciplined one. The lock-up expiration window, the first two quarterly filings, and the first earnings call after IPO each provide information the prospectus cannot. Analysts who build a position only after that evidence exists tend to avoid the worst outcomes, even if they miss the first-day pop.

The workflow that works: set the alert, read the filing when it drops, run the checklist, and size the position according to what the document actually says, not what the roadshow presentation emphasizes.

FilingsIQ cuts S-1 research time for IPO analysts

Reading a 300-page S-1 manually takes hours. Catching a material change buried in amendment 4 of 7 takes even longer without the right tools. FilingsIQ’s IPO analysis platform is built specifically for that problem: it automates the detection of filing changes, extracts key financial ratios from the prospectus, and flags red-flag language across risk factors and MD&A in minutes.

Three capabilities that matter most for IPO research:

• Automated S-1 diffs — Every amendment is compared against the prior version. Changed text is highlighted so you see exactly what the company revised and why it matters.

• Red-flag detection — The platform scans for going-concern language, aggressive revenue recognition disclosures, related-party transaction flags, and governance anomalies.

• Research memo export — A one-page investment-thesis snapshot, ready to share with your team or compliance officer, generated from the filing data.

Filingsiq also tracks insider and congressional trades, giving you a secondary signal layer alongside the filing analysis. Plans range from individual to enterprise tiers. Start with the IPO analysis tool or review pricing options to find the plan that fits your workflow.

Authority sources and where to read the filings

Use these primary sources to monitor filings, calendars, and market commentary:

• SEC EDGAR — The definitive source for all S-1 filings, amendments, comment letters, and withdrawal notices. Free, real-time, and authoritative.

• Nasdaq IPO Calendar — Upcoming, priced, filed, and withdrawn IPOs with estimated dates and price ranges. Best for daily calendar checks.

• Renaissance Capital IPO Center — Deal-level benchmarks, week-ahead previews, and post-IPO return data. The professional standard for IPO market context.

• Yahoo Finance IPO Calendar — Live calendar with exchange, date, and price range columns. Useful for quick cross-referencing.

• Kiplinger Upcoming IPOs — Editorial watchlists with guidance on reading S-1s and sizing positions.

• U.S. News Upcoming IPOs — Curated lists of high-profile names with short analytical context.

• Filingsiq IPO Calendar — Integrated calendar with automated filing-change alerts and workspace tracking for subscribers.

• Filingsiq S-1 Analysis Guide — Step-by-step framework for extracting investment signals from prospectuses.

FAQ

What are the best upcoming IPOs to watch right now?

Databricks, Stripe, Anthropic, OpenAI, Shein, and Intel’s potential spinoff vehicles are the most-watched names for 2026. Databricks is the furthest along, with a confidential S-1 already filed.

Where can you read an S-1 filing before an IPO?

All public S-1 filings and amendments are available free on SEC EDGAR. FilingsIQ’s IPO analysis tool provides AI-generated summaries and diff alerts for each amendment.

How do retail investors get access to IPO shares?

Most retail investors access IPO shares through their brokerage on listing day at the market open price, not the offer price. Some brokerages offer IPO allocation programs for eligible accounts, but institutional investors receive the majority of offer-price allocations.

How much of a portfolio should be allocated to IPOs?

Kiplinger advises keeping total IPO exposure to a small portion of a portfolio at most, treating each position as speculative until the company has reported at least two quarters of public financials.

Which three high-profile IPOs are most anticipated in 2026?

Databricks, Stripe, and Anthropic are consistently cited as the three most anticipated IPOs for 2026 by editorial sources including Kiplinger and U.S. News, based on valuation scale, sector relevance, and investor interest.

---

This article is general information for educational purposes and does not constitute investment advice. Confirm current filing status, valuation estimates, and regulatory conditions with SEC EDGAR or a qualified financial professional before making investment decisions.

Recommended

• Upcoming IPO Calendar 2026 – Companies Going Public Soon | FilingsIQ

• IPO Analysis Tool – AI S-1 Analysis & IPO Research Platform | FilingsIQ

• SEC Filing Analysis Best Practices for Analysts | FilingsIQ.ai

• 5 SEC Filing Red Flags Every RIA Should Watch For | FilingsIQ.ai